In a recent warning letter, the FDA chastised Janssen Vaccines for inconsistent quality control procedures and failure to follow up thoroughly on product complaints—issues that came to light during an inspection of the Johnson & Johnson subsidiary’s manufacturing site in
read morePatientView surveyed a total of 518 patient groups representing dozens of rare diseases. Their responses detail their views of 32 pharmas and the industry at large in 2024. More: Sobi surpasses Roche in rare disease patient groups' reputation rankings Source:
read moreEli Lilly has revealed the location of the second of its four large-scale manufacturing facilities that it plans to build in the U.S., selecting Houston as home to a $6.5 billion API plant for oral drugs. More: Eli Lilly picks
read more
GM CRDC begins trials to assess real-world effectiveness of respiratory vaccines More: Greater Manchester launches first vaccine studies through new research centre Source: News
read more
CHMP backs AstraZeneca and Amgen’s therapy for chronic rhinosinusitis More: Tezspire recommended for EU approval in nasal polyps Source: News
read moreModerna has early in-human data showing its next-generation COVID-19 vaccine, mNEXSPIKE, has the potential to offer strong immune protection against the latest rapidly spreading SARS-CoV-2 virus variant. More: Moderna says updated mNEXSPIKE induces strong immune response against rising COVID-19 strain
read more© 1994 - 2026 B.M. Pharmaceuticals